4-苯磺酰基丁酸 | 6178-52-5

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 中文名称: 4-苯磺酰基丁酸
• 英文名称: 4-(phenylsulfonyl)butanoic acid
• 英文别名: PSOBA；4-benzenesulfonyl-butyric acid；4-Benzolsulfonyl-buttersaeure；4-(phenylsulfonyl)-butanoic acid；4-phenylsulfonylbutanoic acid；4-(benzenesulfonyl)butanoic acid
• CAS: 6178-52-5
• 化学式: C₁₀H₁₂O₄S
• mdl: MFCD07402815
• 分子量: 228.269
• InChiKey: DBHMOMYHWIMTRS-UHFFFAOYSA-N

物化性质

• 熔点：
  90-93 °C(Solv: benzene (71-43-2))
• 沸点：
  475.6±37.0 °C(Predicted)
• 密度：
  1.301±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  1
• 重原子数：
  15
• 可旋转键数：
  5
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.3
• 拓扑面积：
  79.8
• 氢给体数：
  1
• 氢受体数：
  4

安全信息

• 危险等级：
  IRRITANT
• 危险品标志：
  Xi
• 海关编码：
  2916399090

反应信息

• 作为反应物：
  描述：

  4-苯磺酰基丁酸 在 正丁基锂 、 氘代甲醇-d 作用下， 生成 4-deuterio-4-(phenylsulfonyl)butanoic acid
  参考文献：
  名称：

  “远程”双负离子-I。4-苯基磺酰基丁酸在醛和酮向内酯的温和转化中的用途。

  摘要：

  通过用4-苯基磺酰基丁酸和三氟乙酸酐的二价阴离子逐步处理，将酮和醛高产率地转化为内酯。

  DOI：

  10.1016/s0040-4039(00)96475-x
• 作为产物：
  描述：

  4-(phenylthio)butan-1-ol 在 potassium permanganate 、 水 、 溶剂黄146 作用下， 生成 4-苯磺酰基丁酸
  参考文献：
  名称：

  转移反应涉及硼。VI。芳基和烷基硫代硼烷的物理表征和化学性质。

  摘要：

  DOI：

  10.1021/ja00962a021

文献信息

• Substituted (aryl, heteroaryl, arylmethyl or heteroarylmethyl)
  申请人：Rhone-Poulenc Rorer Pharmaceuticals Inc.

  公开号：US06057369A1

  公开（公告）日：2000-05-02

  This invention is directed to compounds of formula I: ##STR1## wherein the variables are as described herein. Compounds within the scope of the present invention possess useful properties, more particularly pharmaceutical properties. They are especially useful for inhibiting the production or physiological effects of TNF in the treatment of a patient suffering from a disease state associated with a physiologically detrimental excess of tumor necrosis factor (TNF). Compounds within the scope of the present invention also inhibit cyclic AMP phosphodiesterase, and are useful in treating a disease state associated with pathological conditions that are modulated by inhibiting cyclic AMP phosphodiesterase, such disease states including inflammatory and autoimmune diseases, in particular type IV cyclic AMP phosphodiesterase. Compounds within the scope of the present invention may also inhibit an MMP, and are useful in treating a disease state associated with pathological conditions that are modulated by inhibiting MMPs, such disease states involve tissue breakdown and those associated with a physiologically detrimental excess of TNF. The present invention is therefore also directed to the pharmaceutical use of the compounds, pharmaceutical compositions containing the compounds, intermediates leading thereto and methods for the preparation of the compounds and their intermediates.

  这项发明涉及到式I的化合物：##STR1## 其中变量如本文所述。本发明范围内的化合物具有有用的性质，更具体地说是药用性质。它们特别适用于抑制TNF的产生或生理效应，用于治疗患有与生理上有害的肿瘤坏死因子（TNF）过量相关的疾病状态的患者。本发明范围内的化合物还抑制环状AMP磷酸二酯酶，并且适用于治疗与通过抑制环状AMP磷酸二酯酶调节的病理条件相关的疾病状态，这些疾病状态包括炎症和自身免疫疾病，特别是第四型环状AMP磷酸二酯酶。本发明范围内的化合物还可能抑制MMP，并且适用于治疗与通过抑制MMPs调节的病理条件相关的疾病状态，这些疾病状态涉及组织分解以及与生理上有害的TNF过量相关的疾病状态。因此，本发明还涉及化合物的药用，含有该化合物的药物组合物，导致该化合物的中间体以及该化合物及其中间体的制备方法。
• Decarboxylative Intramolecular Arene Alkylation Using <i>N</i>-(Acyloxy)phthalimides, an Organic Photocatalyst, and Visible Light
  作者：Trevor C. Sherwood、Hai-Yun Xiao、Roshan G. Bhaskar、Eric M. Simmons、Serge Zaretsky、Martin P. Rauch、Robert R. Knowles、T. G. Murali Dhar

  DOI：10.1021/acs.joc.9b00432

  日期：2019.7.5

  An intramolecular arene alkylation reaction has been developed using the organic photocatalyst 4CzIPN, visible light, and N-(acyloxy)phthalimides as radical precursors. Reaction conditions were optimized via high-throughput experimentation, and electron-rich and electron-deficient arenes and heteroarenes are viable reaction substrates. This reaction enables access to a diverse set of fused, partially

  使用有机光催化剂4CzIPN，可见光和N-（酰氧基）邻苯二甲酰亚胺作为自由基前体，已经开发出分子内芳烃烷基化反应。通过高通量实验优化了反应条件，富电子和缺电子的芳烃和杂芳烃是可行的反应底物。该反应使得能够获得各种各样的熔融的，部分饱和的核，这些核在合成和药物化学中具有很高的意义。
• Direct Catalytic Chemoselective α-Amination of Acylpyrazoles: A Concise Route to Unnatural α-Amino Acid Derivatives
  作者：Keisuke Tokumasu、Ryo Yazaki、Takashi Ohshima

  DOI：10.1021/jacs.5b11773

  日期：2016.3.2

  carboxylic acid oxidation state substrate, while preactivation by a stoichiometric amount of strong base has been used in catalytic α-aminations. The simultaneous activation of both coupling partners, enolization and metal nitrenoid formation, was crucial for obtaining the product, and wide functional group compatibility highlighted the mildness of the present catalysis. The bidentate coordination mode was

  描述了直接铜催化的高化学选择性 α-胺化。酰基吡唑被证明是羧酸氧化态底物的高效烯醇前体，而通过化学计量的强碱预活化已用于催化 α-胺化。偶联伙伴的同时活化、烯醇化和金属氮烯化合物的形成对于获得产品至关重要，广泛的官能团兼容性突出了本催化的温和性。双齿配位模式适用于对酮和更多酸性硝基烷基官能团的高度化学选择性活化。氘交换实验清楚地表明，在不形成硝酸盐的情况下实现了酰基吡唑的排他性烯醇化。目前的催化作用应用于后期 α-胺化，可以简明地获得高度通用的 α-氨基酸衍生物。该产品可以转化为各种有用的积木。
• [EN] CLASS OF HDAC INHIBITORS EXPANDS THE RENAL PROGENITOR CELLS POPULATION AND IMPROVES THE RATE OF RECOVERY FROM ACUTE KIDNEY INJURY<br/>[FR] CLASSE D'INHIBITEURS DE HDAC MULTIPLIANT LA POPULATION DE CELLULES PROGÉNITRICES RÉNALES ET AMÉLIORANT LE TAUX DE RÉCUPÉRATION APRÈS UNE INSUFFISANCE RÉNALE AIGÜE
  申请人：UNIV PITTSBURGH

  公开号：WO2014071000A1

  公开（公告）日：2014-05-08

  Compounds and compositions are provided that inhibit histone deacylase activity and which expand renal progenitor cell populations and improve kidney function in a damaged kidney. Methods of use of the compounds and compositions are provided.

  提供了抑制组蛋白去乙酰化酶活性的化合物和组合物，这些化合物和组合物可以扩大肾脏祖细胞群体，并改善受损肾脏的功能。提供了这些化合物和组合物的使用方法。
• Preparation of Oxepan-2-ones (∊-Lactones)<i>via</i>the Dianion of 4-(Phenylsulfonyl)butanoic Acid
  作者：Kenneth Williams、Charles M. Thompson

  DOI：10.1080/00397919208021298

  日期：1992.1

  Abstract The bis-homoenolate dianion of 4-(phenylsulfonyl)butanoic acid was reacted with terminal oxiranes and cyclized to afford seven-membered lactones in good yield. Preliminary details of this procedure are described.

  摘要 4-(苯磺酰基)丁酸的双高烯醇二阴离子与末端环氧乙烷反应并环化，以良好的收率得到七元内酯。描述了该过程的初步细节。